Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 4
Submit an article Journal homepage
323
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy

Hui Liua Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1452-5062View further author information
ORCID Icon,
Ping Lib Department of Hematology, Tongji Hospital of Tongji University, Shanghai, People’s Republic of ChinaView further author information
,
Aiqi Zhaoa Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information
,
Wen Leia Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information
,
Aibin Liangb Department of Hematology, Tongji Hospital of Tongji University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Wenbin Qiana Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of China;c Institute of Hematology, Zhejiang University, Hangzhou, People’s Republic of China;d National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow UniversityCorrespondence[email protected]
View further author information
Pages 1001-1004 | Received 10 Aug 2021, Accepted 16 Nov 2021, Published online: 28 Nov 2021

References

  • Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-Cell lymphoma. N Engl J Med. 2019;380(1):45–56.
  • Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma. N Engl J Med. 2017;377(26):2531–2544.
  • Liu H, Lei W, Zhang C, et al. CD19-specific CAR T cells that express a PD-1/CD28 chimeric switch-receptor are effective in patients with PD-L1-positive B-Cell Lymphoma. Clin Cancer Res. 2021;27(2):473–484.
  • Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy – assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15(1):47–62.
  • Kim SJ, Kim K, Kim BS, et al. Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma. Clin Lymphoma Myeloma. 2008;8(4):237–240.
  • Aksoy S, Harputluoglu H, Kilickap S, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma. 2007;48(7):1307–1312.
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
  • Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625–638.
  • Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–1349.
  • Los-Arcos I, Iacoboni G, Aguilar-Guisado M, et al. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper. Infection. 2021;49(2):215–231.
  • Strati P, Varma A, Adkins S, et al. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica. 2020;106(10):2667–2672.
  • Coutre SE, Byrd JC, Hillmen P, et al. Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies. Blood Adv. 2019;3(12):1799–1807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.